NOS2P2

Across TCGA pan-cancer cohorts, NOS2P2 RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated NOS2P2 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher NOS2P2 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated NOS2P2 expression acts as an unfavorable survival marker, although some lineages such as BLCA and THYM show a favorable association.

KIRC, OV, and KICH are the cancer types where NOS2P2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	DFS	Tertile	All	0.676	0.825	<.001	144	view →
OV	DFS	Tertile	II,III,IV	0.461	0.577	<.001	76	view →
KICH	DFS	Tertile	II,III,IV	0.474	0.890	.004	60	view →
LIHC	OS	Tertile	All	0.489	0.725	.002	42	view →
STAD	OS	Tertile	All	0.586	0.714	.007	36	view →
BRCA	DFS	Tertile	All	0.570	1.000	.033	36	view →
THCA	DFS	Tertile	All	0.390	0.823	<.001	30	view →
LGG	DFS	Median	All	0.303	0.454	<.001	24	view →
BLCA	OS	Tertile	All	0.836	0.316	.015	18	view →
PCPG	DFS	Tertile	All	0.543	0.865	.002	18	view →
THYM	OS	Tertile	II,III,IV	1.000	0.653	.007	13	view →
ESCA	DFS	Quartile	IV	0.127	0.545	.038	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 17 lineages.

NOS2P2–KIRC (DFS)

Open the KIRC breakdown →